Physician profile
Joshua Smith
NPI 1134588353
$647.47
in general payments reported to CMS, 2019-2025
20 companies · $144 in 2025
The $144 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $102 · 2022: $63.19 · 2023: $106 · 2024: $233 · 2025: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $483.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $482.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $95.43 | 2024-2025 | |
| Ferring Pharmaceuticals INC. | $63.95 | 2022-2025 | Euflexxa |
| Boston Scientific Corporation | $49.98 | 2024-2025 | Wavewriter Alpha Prime 16 |
| Pacira Pharmaceuticals Incorporated | $49.86 | 2024 | Zilretta, Iovera, Exparel |
| Djo, LLC | $48.86 | 2023-2024 | Cmf |
| Pacira Therapeutics, INC. | $44.27 | 2021 | |
| Abbvie INC. | $43.53 | 2022-2025 | |
| Depuy Synthes Sales INC. | $29.75 | 2024 | Healix Knotless Peek, Dynatape |
| Solventum Corporation | $27.42 | 2024-2025 | V.A.C. Veraflo, Activ.A.C. |
| Averitas Pharma INC. | $24.33 | 2023 | Qutenza |
| Bioventus LLC | $24.13 | 2021 | |
| Medtronic, INC. | $19.36 | 2024 | Intellis Adaptivestim |
| Radius Health, INC. | $17.60 | 2021 | |
| Organogenesis INC. | $16.81 | 2023 | Puraply |
| Kerecis Limited | $16.29 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $15.91 | 2022 | |
| Endo USA, INC. | $15.67 | 2025 | Xiaflex |
| Endo Pharmaceuticals INC. | $15.61 | 2021 | |
| Fidia Pharma USA INC. | $14.63 | 2022 | |
| Amgen INC. | $14.08 | 2024 | Prolia, Evenity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.